Does Tribulus Terrestris Work for Women's Libido? What 2 Clinical Trials Found
Share
Tribulus terrestris is one of the few botanicals tested for women's libido in randomized placebo-controlled trials, and the trials came back positive. Desire scores rose significantly versus placebo in premenopausal women within 4 weeks and in postmenopausal women within 90 days (Akhtari et al., DARU, 2014; Postigo et al., Revista Brasileira de Ginecologia e Obstetricia, 2016). That sentence is rare in this category. Most ingredients sold for desire have rodent data and a wink. This one has human trials with control groups, which is exactly the standard we think you should hold any ingredient to, including ours.
What Is Tribulus Terrestris?
A spiky little vine that grows on most continents, used for centuries in both Ayurvedic and traditional Chinese practice. You've probably seen it in the gym aisle, marketed to men with shirtless-stock-photo confidence. The irony, and we cover this in our full Tribulus terrestris guide, is that the strongest human evidence for Tribulus isn't about muscle or men at all. It's about desire in women.
What Did the First Trial Find in Premenopausal Women?
In 2014, researchers at Tehran University of Medical Sciences ran a randomized, double-blind, placebo-controlled trial in 67 women of fertile age who had been diagnosed with hypoactive sexual desire disorder, the formal term clinicians use for persistent low desire that bothers the person experiencing it (Akhtari et al., DARU Journal of Pharmaceutical Sciences, 2014). For 4 weeks, half took a Tribulus terrestris extract and half took placebo, with 30 women in each group completing the study.
The Tribulus group scored significantly higher on the Female Sexual Function Index, the standard questionnaire in this research. Desire improved with p under 0.001. So did arousal, lubrication, satisfaction, and pain scores. Side effects? Statistically the same as placebo.
Four weeks is a short trial, but that cuts both ways: it also means the change showed up fast enough to measure in a month.
What Happened in Postmenopausal Women?
A Brazilian team at Santa Casa de Sao Paulo ran the same design in a harder population: 60 postmenopausal women reporting low desire, randomized to Tribulus or placebo for 90 days (Postigo et al., 2016). Menopause is where desire complaints concentrate and where most botanicals quietly fail, so this is the trial worth watching.
The Tribulus group ended with desire and sexual interest scores of 10.2 versus 7.6 for placebo, significant at p of 0.001 or less. The self-reported improvement numbers were larger still: vaginal lubrication improved for 83.3 percent of the Tribulus group versus 20 percent on placebo, genital sensation for 76.7 versus 16.7 percent, and the ability to reach orgasm for 73.3 versus 20 percent.
Now the part the sales pages skip. On the Sexual Quotient questionnaire, the orgasm and satisfaction domain showed no significant difference between groups, p equals 0.28. The same women who reported better orgasm ability on one instrument didn't separate from placebo on another. That's what small-trial evidence looks like up close: real signal, fuzzy edges. Anyone who quotes you the 73 percent without the p of 0.28 is selling, not summarizing.
| Akhtari 2014 (Iran) | Postigo 2016 (Brazil) | |
|---|---|---|
| Design | Randomized, double-blind, placebo-controlled | Randomized, double-blind, placebo-controlled |
| Who | 67 premenopausal women with diagnosed low desire | 60 postmenopausal women reporting low desire |
| How long | 4 weeks | 90 days |
| Desire result | Improved vs placebo, p < 0.001 (FSFI) | 10.2 vs 7.6, p ≤ 0.001 (SQ-F) |
| Also improved | Arousal, lubrication, satisfaction, pain | Lubrication (83.3% vs 20%), sensation, orgasm ability |
| What didn't move | Orgasm domain not significant | Orgasm and satisfaction domain, p = 0.28 |
| Side effects | Same as placebo | Same as placebo |
Is It a Testosterone Thing?
Here's where the gym marketing falls apart and the women's data gets more interesting. A 2005 study gave Tribulus to healthy young men for 4 weeks and measured their hormones: testosterone didn't budge (Neychev and Mitev, Journal of Ethnopharmacology, 2005). That null result has been replicated enough that "Tribulus raises testosterone in men" is a claim the research doesn't back, and we'd rather tell you that plainly than borrow the hype.
But in postmenopausal women, a third randomized placebo-controlled trial, published in the journal Menopause in 2016, found desire improved versus placebo and free and bioavailable testosterone levels rose in the Tribulus group (de Souza et al., 2016). Same plant, opposite hormonal result, different population. The likely reading: women start from much lower testosterone, especially after menopause, so a nudge that's invisible in a 25-year-old man may matter in a 55-year-old woman. The mechanism question isn't settled, and we're not going to pretend it is. What's settled is the pattern: three controlled trials in women, three desire improvements.
The Honest Caveats
If we held our own ingredients to a softer standard than the ones we critique, you should stop reading us. So here is the full caveat list:
- The trials are small. Thirty to 36 women per group. Real randomized evidence, but not the thousands-strong trials drugs get.
- They're short. Four weeks to 120 days. Nobody has published what year two looks like.
- Desire is self-reported. There's no blood test for wanting. Validated questionnaires are the best tool available, and they're still questionnaires.
- Not every measure moved. The orgasm and satisfaction domain stayed flat in the Postigo trial. A supplement that improves desire and lubrication but not orgasm scores is a believable, specific result. A supplement that fixes everything is a red flag.
- Extracts vary. Tribulus products differ wildly in active saponin content depending on plant part and origin. The bottle at a gas station is not automatically the extract from these trials.
With all of that said: two positive placebo-controlled trials plus a third pointing the same way is a stronger human evidence base than almost any botanical in the desire category. We hold Tribulus up against the same bar we use to knock down overhyped ingredients, and it clears it.
Where It Fits in a Formula
Tribulus terrestris is one of the four botanicals in NUUD's non-hemp formula, alongside muira puama, rehmannia root, and our NUUD Mushroom Complex. We put it there because of the trials you just read, not because it photographs well next to a dumbbell. If you want to feel what a Tribulus-led formula does, the women's libido gummies are the place to start, and the arousal supplements hub breaks down how the whole formula works and when to take it.
And if you're still in research mode, good. That's the right mode. Our guides on low libido in women and rehmannia root are written the same way this one is: studies first, sell last.
Frequently Asked Questions
Does tribulus terrestris work for women's libido?
Two randomized placebo-controlled trials say yes. Premenopausal women with diagnosed low desire improved significantly versus placebo in 4 weeks (Akhtari 2014), and postmenopausal women scored 10.2 versus 7.6 on desire after 90 days (Postigo 2016). A third trial in the journal Menopause found the same direction.
How long does tribulus terrestris take to work for women?
The measured windows run from 4 weeks to 4 months. The premenopausal trial recorded significant desire improvement after 4 weeks of daily use, and the postmenopausal trials measured their results at 90 and 120 days. No trial has tested single-dose or same-day effects of Tribulus alone.
Does tribulus terrestris raise testosterone in women?
In postmenopausal women, one randomized trial found free and bioavailable testosterone rose alongside desire (de Souza 2016). In healthy young men, a controlled study found no testosterone change at all (Neychev 2005). The hormonal effect appears to depend on where you start, and the mechanism isn't settled.
Is tribulus terrestris safe for women?
In both anchor trials, side-effect rates in the Tribulus groups were statistically the same as placebo over 4 weeks and 90 days. Long-term safety data beyond 120 days hasn't been published, and anyone pregnant, nursing, or on medication should check with their doctor first.
Does tribulus terrestris help with menopause-related low desire?
This is where the evidence is strongest. Both postmenopausal trials, Postigo 2016 and de Souza 2016, were randomized and placebo-controlled, and both found significant desire improvement in the Tribulus group. Lubrication improved for 83.3 percent of Tribulus users versus 20 percent on placebo in the Postigo trial.
References:
- Akhtari E, Raisi F, Keshavarz M, et al. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo-controlled study. DARU J Pharm Sci. 2014;22(1):40. PMID 24773615 / PMC4045980
- Postigo S, Lima SM, Yamada SS, et al. Assessment of the Effects of Tribulus Terrestris on Sexual Function of Menopausal Women. Rev Bras Ginecol Obstet. 2016;38(3):140-146. PMID 26902700 / PMC10309463
- de Souza KZ, Vale FB, Geber S. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial. Menopause. 2016;23(11):1252-1256. PMID 27760089
- Neychev VK, Mitev VI. The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men. J Ethnopharmacol. 2005;101(1-3):319-323. PMID 15994038
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The studies cited tested Tribulus terrestris extracts on their own, not NUUD products.